CYRX vs SRPT · rev $96.8M vs rev $1.13B
Cryoport Inc (CYRX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Cryoport Inc (CYRX) is a integrated freight & logistics company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CYRX revenue for 2026-06-30 was $96.8M. Net income was -$18.8M. CYRX currently screens at market cap $365.5M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CYRX currently screens at market cap $365.5M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CYRX and SRPT stock pages for the full models.
Not investment advice.